Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.9.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.9.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.9.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.47.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.47.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.47.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.51NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KU.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KU.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KZ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KZ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JQ.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JQ.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JQ.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LA.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LA.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LA.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used